Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 17 studies | 34% ± 13% | |
astrocyte | 13 studies | 38% ± 17% | |
glutamatergic neuron | 10 studies | 52% ± 25% | |
oligodendrocyte precursor cell | 10 studies | 40% ± 17% | |
macrophage | 9 studies | 29% ± 12% | |
microglial cell | 9 studies | 40% ± 10% | |
adipocyte | 9 studies | 41% ± 9% | |
fibroblast | 9 studies | 28% ± 6% | |
oligodendrocyte | 9 studies | 35% ± 11% | |
GABAergic neuron | 8 studies | 49% ± 24% | |
mast cell | 7 studies | 23% ± 6% | |
smooth muscle cell | 7 studies | 25% ± 6% | |
epithelial cell | 6 studies | 24% ± 7% | |
interneuron | 6 studies | 58% ± 23% | |
dendritic cell | 6 studies | 22% ± 3% | |
endothelial cell of lymphatic vessel | 6 studies | 35% ± 8% | |
type II pneumocyte | 6 studies | 34% ± 11% | |
pericyte | 6 studies | 22% ± 4% | |
neuron | 5 studies | 39% ± 19% | |
retinal cone cell | 5 studies | 28% ± 8% | |
cardiac muscle cell | 5 studies | 32% ± 9% | |
type I pneumocyte | 5 studies | 31% ± 6% | |
mesothelial cell | 4 studies | 30% ± 10% | |
amacrine cell | 4 studies | 28% ± 2% | |
retina horizontal cell | 4 studies | 26% ± 6% | |
retinal rod cell | 4 studies | 24% ± 4% | |
myeloid cell | 4 studies | 32% ± 6% | |
club cell | 4 studies | 31% ± 8% | |
monocyte | 4 studies | 28% ± 7% | |
GABAergic interneuron | 3 studies | 47% ± 1% | |
plasma cell | 3 studies | 24% ± 3% | |
GABAergic amacrine cell | 3 studies | 27% ± 5% | |
Mueller cell | 3 studies | 27% ± 3% | |
glycinergic amacrine cell | 3 studies | 26% ± 6% | |
retinal ganglion cell | 3 studies | 25% ± 5% | |
hepatocyte | 3 studies | 51% ± 13% | |
B cell | 3 studies | 22% ± 6% | |
T cell | 3 studies | 22% ± 5% | |
alveolar macrophage | 3 studies | 32% ± 7% | |
ciliated cell | 3 studies | 26% ± 5% | |
respiratory goblet cell | 3 studies | 34% ± 11% | |
basal cell | 3 studies | 25% ± 5% | |
mucus secreting cell | 3 studies | 30% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 993.86 | 245 / 245 | 97% | 1.72 | 489 / 502 |
adrenal gland | 100% | 1653.63 | 258 / 258 | 94% | 1.74 | 216 / 230 |
uterus | 100% | 891.89 | 170 / 170 | 94% | 1.93 | 430 / 459 |
thymus | 100% | 1026.19 | 653 / 653 | 93% | 1.78 | 564 / 605 |
breast | 100% | 824.51 | 459 / 459 | 89% | 1.66 | 992 / 1118 |
pancreas | 100% | 497.01 | 328 / 328 | 84% | 1.32 | 149 / 178 |
bladder | 100% | 822.95 | 21 / 21 | 81% | 1.60 | 406 / 504 |
esophagus | 100% | 734.57 | 1445 / 1445 | 79% | 1.38 | 145 / 183 |
brain | 100% | 841.68 | 2642 / 2642 | 77% | 1.19 | 540 / 705 |
lung | 100% | 726.73 | 578 / 578 | 72% | 1.36 | 837 / 1155 |
intestine | 100% | 771.05 | 966 / 966 | 64% | 1.02 | 339 / 527 |
skin | 100% | 769.94 | 1809 / 1809 | 62% | 0.91 | 291 / 472 |
stomach | 100% | 653.18 | 359 / 359 | 58% | 1.08 | 167 / 286 |
kidney | 100% | 860.75 | 89 / 89 | 50% | 0.78 | 448 / 901 |
ovary | 100% | 951.17 | 180 / 180 | 50% | 0.70 | 213 / 430 |
liver | 100% | 607.68 | 226 / 226 | 42% | 0.63 | 171 / 406 |
adipose | 100% | 767.75 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 804.84 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 705.02 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 100% | 467.65 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 562.59 | 848 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 1.30 | 26 / 29 |
peripheral blood | 81% | 380.78 | 749 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 69% | 0.97 | 31 / 45 |
eye | 0% | 0 | 0 / 0 | 41% | 0.64 | 33 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_0032204 | Biological process | regulation of telomere maintenance |
GO_0007064 | Biological process | mitotic sister chromatid cohesion |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0040029 | Biological process | epigenetic regulation of gene expression |
GO_0031647 | Biological process | regulation of protein stability |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0000228 | Cellular component | nuclear chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0033558 | Molecular function | protein lysine deacetylase activity |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0051879 | Molecular function | Hsp90 protein binding |
GO_0004407 | Molecular function | histone deacetylase activity |
GO_0030544 | Molecular function | Hsp70 protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0160009 | Molecular function | histone decrotonylase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | HDAC8 |
Protein name | Histone deacetylase 8 (HD8) (EC 3.5.1.98) (Protein deacetylase HDAC8) (EC 3.5.1.-) (Protein decrotonylase HDAC8) (EC 3.5.1.-) Histone deacetylase 8 (HD8) (EC 3.5.1.98) Histone deacetylase 8 (EC 3.5.1.98) (Protein deacetylase HDAC8) (Protein decrotonylase HDAC8) histone deacetylase (EC 3.5.1.98) Histone deacetylase 8 |
Synonyms | CDA07 HDACL1 |
Description | FUNCTION: Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) . Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events . Histone deacetylases act via the formation of large multiprotein complexes . Also involved in the deacetylation of cohesin complex protein SMC3 regulating release of cohesin complexes from chromatin . May play a role in smooth muscle cell contractility . In addition to protein deacetylase activity, also has protein-lysine deacylase activity: acts as a protein decrotonylase by mediating decrotonylation ((2E)-butenoyl) of histones . . FUNCTION: Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Also involved in the deacetylation of cohesin complex protein SMC3 regulating release of cohesin complexes from chromatin. May play a role in smooth muscle cell contractility. In addition to protein deacetylase activity, also has protein-lysine deacylase activity: acts as a protein decrotonylase by mediating decrotonylation ((2E)-butenoyl) of histones. . FUNCTION: Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Also involved in the deacetylation of cohesin complex protein SMC3 regulating release of cohesin complexes from chromatin. May play a role in smooth muscle cell contractility. In addition to protein deacetylase activity, also has protein-lysine deacylase activity: acts as a protein decrotonylase by mediating decrotonylation ((2E)-butenoyl) of histones. . FUNCTION: Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Also involved in the deacetylation of cohesin complex protein SMC3 regulating release of cohesin complexes from chromatin. May play a role in smooth muscle cell contractility. In addition to protein deacetylase activity, also has protein-lysine deacylase activity: acts as a protein decrotonylase by mediating decrotonylation ((2E)-butenoyl) of histones. . FUNCTION: Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Also involved in the deacetylation of cohesin complex protein SMC3 regulating release of cohesin complexes from chromatin. May play a role in smooth muscle cell contractility. In addition to protein deacetylase activity, also has protein-lysine deacylase activity: acts as a protein decrotonylase by mediating decrotonylation ((2E)-butenoyl) of histones. . FUNCTION: Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Also involved in the deacetylation of cohesin complex protein SMC3 regulating release of cohesin complexes from chromatin. May play a role in smooth muscle cell contractility. In addition to protein deacetylase activity, also has protein-lysine deacylase activity: acts as a protein decrotonylase by mediating decrotonylation ((2E)-butenoyl) of histones. . |
Accessions | ENST00000650604.1 C9J8F0 ENST00000647980.1 ENST00000373589.9 [Q9BY41-4] A0A3B3IT84 ENST00000436675.6 ENST00000647974.1 ENST00000649116.1 [Q9BY41-8] A0A3B3IRZ8 A0A3B3IT30 A0A3B3IRZ0 ENST00000649181.1 A0A3B3IUD1 ENST00000648504.1 A0A3B3IS08 ENST00000647886.1 ENST00000647606.1 A0A3B3IU21 ENST00000373583.6 ENST00000648036.1 A0A3B3ISE4 ENST00000648731.1 A6NMT1 ENST00000649097.1 A0A3B3ISN6 ENST00000648276.1 ENST00000415409.6 ENST00000650471.1 A6NGJ7 A0A3B3ISS7 ENST00000648870.1 ENST00000649518.1 ENST00000650636.1 A6NGT0 A0A3B3ITV2 ENST00000648459.1 A0A3B3IU52 A6NFW1 ENST00000648452.1 ENST00000647594.1 ENST00000649242.1 A0A3B3IS37 E7EW22 ENST00000647654.1 A0A3B3ISG7 A0A3B3IT04 ENST00000650076.1 ENST00000470998.2 A0A3B3ISY0 A0A3B3ITZ3 ENST00000648850.1 F8WCG4 A0A3B3IT95 ENST00000648298.1 ENST00000373559.8 [Q9BY41-6] A0A3B3IS68 A0A3B3IU62 ENST00000648139.1 ENST00000373556.8 [Q9BY41-7] ENST00000650126.1 A0A3B3ISP0 ENST00000648577.1 A0A3B3IT98 ENST00000373571.6 ENST00000373573.9 [Q9BY41-1] A0A3B3IU01 A0A3B3IRI9 ENST00000421523.6 ENST00000647859.1 A0A3B3IRP8 ENST00000439122.7 [Q9BY41-5] ENST00000373554.6 [Q9BY41-8] ENST00000412342.6 ENST00000648711.1 ENST00000373560.7 ENST00000648962.1 ENST00000648939.1 Q9BY41 ENST00000649543.1 A0A3B3IRJ3 ENST00000648834.1 A0A3B3ISB8 ENST00000373568.7 ENST00000649752.1 A0A3B3IRJ8 ENST00000649274.1 A0A3B3ISJ4 E7EVA8 A0A3B3IS93 |